Pu J, Yu Y, Liu Y, Tian L, Gui S, Zhong X, et al
In the context of precision medicine, developing optimized GLP-1RAs treatment plans based on individual cancer risk profiles while balancing diabetes management remains an urgent clinical challenge
Semaglutide, a GLP-1 receptor agonist, was developed to help people manage blood sugar and lose weightbut emerging clinical data suggests it may also improve cholesterol profiles
The DPP-4 enzyme (dipeptidyl peptidase-4) rapidly degrades active GLP-1 hormone, reducing its circulating half-life to just 2-3 minutes
These studies offer new insights for the future development of antifungal medications
SFs have an intact endogenous dopamine system in which D1R is overexpressed, promoting the migration of RASF cells, leading to a strong increase of SF migration in young patients (146), and decreased release of IL-6 and IL-8